Goldman Sachs
IQMDW

Goldman Sachs’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Goldman Sachs’s Portfolio IQMDW Stock Details IQMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-65,069
Closed -$696 – 6377
2022
Q4 		$696 Sell
65,069
-31,357
-33% -$944 ﹤0.01% 5913
2022
Q3 		$9K Sell
96,426
-1,873
-2% -$202 ﹤0.01% 6041
2022
Q2 		$13K Sell
98,299
-2,768
-3% -$560 ﹤0.01% 6239
2022
Q1 		$28K Buy
+101,067
New +$36.8K ﹤0.01% 6370

Other funds holding IQMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Goldman Sachs's IQMDW Position: Q1 2023 in Review

Goldman Sachs sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q1 2023, closing a stake of 65,069 shares — an estimated $696 sold.

Goldman Sachs first reported a position in IQMDW in Q1 2022 and held it in 4 quarters. The position peaked at $28K in Q1 2022. 49 funds tracked by Wall St. Rank hold IQMDW as of Q1 2023.

  • Goldman Sachs reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
  • Goldman Sachs sold 65,069 Intelligent Medicine Acquisition Corp. Warrant shares in Q1 2023, an estimated $696.
  • Goldman Sachs first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q1 2022 and held it in 4 quarters.
  • Goldman Sachs's Intelligent Medicine Acquisition Corp. Warrant position peaked at $28K in Q1 2022.
  • 49 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q1 2023.

Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.